Clinical trials
Diabetes Mellitus, Type 2 trials in Australia with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 5 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 5 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayside Health | 4 |
| University of Adelaide | 4 |
| Endogenex, Inc. | 3 |
| Garvan Institute of Medical Research | 3 |
| Medtronic MiniMed, Inc. | 3 |
| Baker Heart Research Institute | 2 |
| Monash University | 2 |
| Australian Catholic University | 1 |
| GT Metabolic Solutions, Inc. | 1 |
| Hunter and New England Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 31 |
| Insulin Resistance | 8 |
| Obesity | 6 |
| Diabetes Mellitus | 5 |
| Diabetes Mellitus, Type 1 | 4 |
| Cardiovascular Diseases | 3 |
| Hypoxia | 2 |
| Inflammation | 2 |
| Coronary Disease | 1 |
| Glucose Intolerance | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.